Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iProven is a consumer health and home medical device brand operated by Masena Invest that develops and sells professional-style health products for home use. Its portfolio includes thermometers, blood pressure monitors, pulse oximeters, fertility and ovulation tracking products, and other personal health devices. The company positions itself around ease of use, consumer accessibility, and clinically oriented measurement tools for adults, children, babies, and fertility users. iProven also offers Bluetooth-enabled devices that integrate with the MedM Health app for tracking and sharing measurements. Overall, iProven appears to be a commercial-stage home healthcare device company rather than a therapeutics developer or biotech pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iProven.